Gilead Sciences, Inc [NASDAQ: GILD] traded at a high on 2025-07-01, posting a 0.78 gain after which it closed the day’ session at $9250000.0.
The results of the trading session contributed to over 7501860 shares changing hands. Over the past one week, the price volatility of Gilead Sciences, Inc stands at 2.43% while the volatility over the past one month is 2.59%.
The market cap for GILD stock reached $138.98 billion, with 1.25 billion shares outstanding and 1.24 billion shares in the current float. Compared to the average trading volume of 9.25M shares, GILD reached a trading volume of 7501860 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Gilead Sciences, Inc [GILD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GILD shares is $117.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GILD stock is a recommendation set at 1.87. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Gilead Sciences, Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 22, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price from $115 to $132. The new note on the price target was released on March 04, 2025, representing the official price target for Gilead Sciences, Inc stock. Previously, the target price had yet another raise to $120, while Deutsche Bank analysts kept a Buy rating on GILD stock.
The Price to Book ratio for the last quarter was 7.26, with the Price to Cash per share for the same quarter was set at 7.34. Price to Free Cash Flow for GILD in the course of the last twelve months was 14.12 with Quick ratio for the last quarter at 1.23.
How has GILD stock performed recently?
Gilead Sciences, Inc [GILD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.23. With this latest performance, GILD shares gained by 1.50% in over the last four-week period, additionally plugging by 18.35% over the last 6 months – not to mention a rise of 20.96% in the past year of trading.
Gilead Sciences, Inc [GILD]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Gilead Sciences, Inc [GILD] shares currently have an operating margin of 38.01% and a Gross Margin at 78.25%. Gilead Sciences, Inc’s Net Margin is presently recorded at 20.79%.
Return on Equity for this stock inclined to 10.58%, with Return on Assets sitting at 10.58%.
Earnings analysis for Gilead Sciences, Inc [GILD]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GILD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gilead Sciences, Inc go to 26.05%.
Insider trade positions for Gilead Sciences, Inc [GILD]
There are presently around $89.60%, or 89.70%% of GILD stock, in the hands of institutional investors. The top three institutional holders of GILD stocks are: BLACKROCK INC. with ownership of 120.63 million shares, which is approximately 9.6738%. VANGUARD GROUP INC, holding 115.26 million shares of the stock with an approximate value of $$7.91 billion in GILD stocks shares; and VANGUARD GROUP INC, currently with $$5.23 billion in GILD stock with ownership which is approximately 6.1147%.
